These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 18723841)

  • 41. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is cannabis use a contributory cause of psychosis?
    Degenhardt L; Hall W
    Can J Psychiatry; 2006 Aug; 51(9):556-65. PubMed ID: 17007222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of COMT genotype on cognitive ability and functional capacity in individuals with schizophrenia.
    Twamley EW; Hua JP; Burton CZ; Vella L; Chinh K; Bilder RM; Kelsoe JR
    Schizophr Res; 2014 Oct; 159(1):114-7. PubMed ID: 25139113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Baudin G; Godin O; Lajnef M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Fond G; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Tronche AM; Misdrahi D; Rey R; Passerieux C; Schandrin A; Urbach M; Vidalhet P; Llorca PM; Schürhoff F;
    Schizophr Res; 2016 Aug; 175(1-3):161-167. PubMed ID: 27209524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabis and psychosis.
    Degenhardt L; Hall W
    Curr Psychiatry Rep; 2002 Jun; 4(3):191-6. PubMed ID: 12003681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.
    Hall W; Degenhardt L
    BMJ; 2015 Mar; 350():h1205. PubMed ID: 25739398
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of cannabis and endocannabinoids in the genesis of schizophrenia.
    Fernandez-Espejo E; Viveros MP; Núñez L; Ellenbroek BA; Rodriguez de Fonseca F
    Psychopharmacology (Berl); 2009 Nov; 206(4):531-49. PubMed ID: 19629449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis and psychosis/schizophrenia: human studies.
    D'Souza DC; Sewell RA; Ranganathan M
    Eur Arch Psychiatry Clin Neurosci; 2009 Oct; 259(7):413-31. PubMed ID: 19609589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabis and psychosis revisited.
    Damjanović A; Pantović M; Damjanović A; Dunjić-Kostić B; Ivković M; Milovanović S; Lacković M; Dimitrijević I
    Psychiatr Danub; 2015 Mar; 27(1):97-100. PubMed ID: 25751443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.
    Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M
    Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cannabis use and age at onset of schizophrenia.
    Veen ND; Selten JP; van der Tweel I; Feller WG; Hoek HW; Kahn RS
    Am J Psychiatry; 2004 Mar; 161(3):501-6. PubMed ID: 14992976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.
    Ermis A; Erkiran M; Dasdemir S; Turkcan AS; Ceylan ME; Bireller ES; Cakmakoglu B
    In Vivo; 2015; 29(1):129-32. PubMed ID: 25600541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Environmental studies of schizophrenia through the prism of epigenetics.
    Oh G; Petronis A
    Schizophr Bull; 2008 Nov; 34(6):1122-9. PubMed ID: 18703665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What is the mechanism whereby cannabis use increases risk of psychosis?
    Luzi S; Morrison PD; Powell J; di Forti M; Murray RM
    Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.